Kinase inhibitors are one of the current cancer treatments. Verzenio with the active ingredient Abemaciclib is a drug that acts by this mechanism, specifically inhibiting CDK4 and CDK6.

On October 13, 2021, FDA (Food and Drug Administration) – US approved a new drug for the treatment of early breast cancer, believed to be the first real progress in 20 years. five. The drug is called abemaciclib - brand name Verzenio. So what is that drug? What effect? Learn about new drugs for early-stage breast cancer.